JIPYONG LLC

[Notice]Jipyong Capital Markets Group Publishes 'Jipyong IPO Practice Research (2025)'

[Notice]Jipyong Opens Continued Listing Advisory Center for Listed Companies

[Notice]JIPYONG Established Jipyong IP

Jipyong Expands and Restructures its Management & Shareholder Disputes Center

Jipyong and Jipyong IP Sign MOU with Xlife Sciences and Co-Host NASDAQ Listing Seminar for Pharmaceutical and Biotech Companies

Preferential Rights and Differential Treatment of Shareholders in Korea

Amendment to the Financial Investment Services and Capital Markets Act: Mandatory Prior Disclosure of Insider Trading for Listed Companies

2023 in Review & 2024 Outlook by Practice Chairs